PharmaCyte Updates Status Of Investigational New Drug Application For Pancreatic Cancer Candidate
February 14, 2022 at 12:08 PM EST
PharmaCyte Biotech Inc(NASDAQ: PMCB)updated its activities to lift the FDA's clinical holdon PharmaCyte's ...